Liver Cancer Trial, Recruiting NCT06745895 Sponsor: H. Lee Moffitt Cancer Center and Research Institute Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06745895
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You receive your healthcare at one of the clinics taking part in this study.
  • You are between 45 and 75 years old.
  • You are not up to date with colorectal cancer (bowel cancer) screening — for example, you have not had a colonoscopy in the last 10 years or a stool blood test in the last 12 months.
  • You have never been tested for Hepatitis C (a liver infection spread through blood contact).
  • You can read, write, and understand English or Spanish.
  • You have never been diagnosed with colorectal cancer and do not currently have symptoms such as unexplained rectal bleeding or ongoing stomach pain or bloating.
  • You are considered average risk for colorectal cancer — meaning you do not have an inherited condition that raises your risk and do not have a strong family history of colorectal cancer.
  • You do not currently have any symptoms of Hepatitis C.
  • If you are taking part in the main part of the study, you are willing and able to fill out surveys and take part in the program activities.
  • If you are taking part in an interview portion, you are willing to do a remote interview by phone or video call (such as Zoom).
  • If you are taking part in an interview, you are willing to have the conversation audio recorded.
  • If you are being interviewed but did not take part in the main program, you have had a clinic visit within the past two months.
  • You are able to give your informed consent to take part in the study.

Who may not be able to join:

  • Anyone who does not meet all of the requirements listed above will not be eligible to take part.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shannon Christy, PhD, Moffitt Cancer Center

Phone: 813-745-8963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 October 2024
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Screening Uptake for Hepatitis C Virus (HCV) and Colorectal Cancer (CRC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov